Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages II
RNA-seq (gene expression) · mouse · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 30 samples: 15 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299507_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1274869 and SRA study SRP591330. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 15 replicated groups read from 30 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9039982 vehicle: 5%glucose ip, PBS it, rep1, day3 5%glucose ip, PBS it, r…
- GSM9039983 vehicle: 5%glucose ip, PBS it, rep2, day3 5%glucose ip, PBS it, r…
- GSM9039984 vehicle: 5%glucose ip, PBS it, rep3, day3 5%glucose ip, PBS it, r…
- GSM9039985 OXP: oxaliplatin ip, PBS it. rep1, day3 oxaliplatin ip, PBS it.…
- GSM9039986 OXP: oxaliplatin ip, PBS it. rep2, day3 oxaliplatin ip, PBS it.…
- GSM9039987 OXP: oxaliplatin ip, PBS it. rep3, day3 oxaliplatin ip, PBS it.…
- GSM9039988 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep1, day3 5%glucose ip, hIL-7/mIL…
- GSM9039989 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep2, day3 5%glucose ip, hIL-7/mIL…
- GSM9039990 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep3, day3 5%glucose ip, hIL-7/mIL…
- GSM9039991 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep1, day3 oxaliplatin ip, hIL-7/m…
- GSM9039992 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep2, day3 oxaliplatin ip, hIL-7/m…
- GSM9039993 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep3, day3 oxaliplatin ip, hIL-7/m…
- GSM9039994 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep1, day3 5%glucose ip, hIL-7/mIL…
- GSM9039995 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep2, day3 5%glucose ip, hIL-7/mIL…
- GSM9039996 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep3, day3 5%glucose ip, hIL-7/mIL…
- GSM9039997 vehicle: 5%glucose ip, PBS it, rep1, day7 5%glucose ip, PBS it, r…
- GSM9039998 vehicle: 5%glucose ip, PBS it, rep2, day7 5%glucose ip, PBS it, r…
- GSM9039999 vehicle: 5%glucose ip, PBS it, rep3, day7 5%glucose ip, PBS it, r…
- GSM9040000 OXP: oxaliplatin ip, PBS it. rep1, day7 oxaliplatin ip, PBS it.…
- GSM9040001 OXP: oxaliplatin ip, PBS it. rep2, day7 oxaliplatin ip, PBS it.…
- GSM9040002 OXP: oxaliplatin ip, PBS it. rep3, day7 oxaliplatin ip, PBS it.…
- GSM9040003 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep1, day7 5%glucose ip, hIL-7/mIL…
- GSM9040004 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep2, day7 5%glucose ip, hIL-7/mIL…
- GSM9040005 VV(2e6)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E6 pfu it, rep3, day7 5%glucose ip, hIL-7/mIL…
- GSM9040006 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep1, day7 oxaliplatin ip, hIL-7/m…
- GSM9040007 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep2, day7 oxaliplatin ip, hIL-7/m…
- GSM9040008 VV(2e6)+OXP: oxaliplatin ip, hIL-7/mIL-12-VV 2E6 pfu it, rep3, day7 oxaliplatin ip, hIL-7/m…
- GSM9040009 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep1, day7 5%glucose ip, hIL-7/mIL…
- GSM9040010 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep2, day7 5%glucose ip, hIL-7/mIL…
- GSM9040011 VV(2e7)-mono: 5%glucose ip, hIL-7/mIL-12-VV 2E7 pfu it, rep3, day7 5%glucose ip, hIL-7/mIL…
- GSE299508 Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages III 12 samples shares reorganization, intratumoral, combination, oxaliplatin, virotherapy, macrophages, oncolytic, improves
- GSE183687 Transcriptomic profiling of isolated hepatic macrophage subsets (Kupffer cells, Monocyte-derived Macrophages and Monocytes) in common bile duct ligated (CBDL)-mice, mice with acute colitis (DSS), and combinations (CBDL+DSS) 58 samples shares combination, macrophages
- GSE235291 Combination therapy with oncolytic virus and adoptively transferred T cells or mRNA vaccine amplifies antitumor effects 24 samples shares combination, oncolytic
- GSE287619 Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes 15 samples shares combination, improves
- GSE235289 Combination therapy with oncolytic virus and adoptively transferred T cells or mRNA vaccine amplifies antitumor effects [RNA-Seq] 12 samples shares combination, oncolytic
- GSE275444 Human-correlated genetic HCC and HCC-organoid models identify combination therapy for precision medicine 216 samples shares combination
- GSE284500 Transcriptional profiling of hippocampus from a zQ175 KI mouse model of Huntington's disease treated with either HTT-10150 siRNA targeting full-length HTT or combination of HTT-634 and HTT-486 siRNAs targeting HTT1a 192 samples shares combination
- GSE342349 CT26 multi-tissue RNA-seq under immunotherapy combinations 72 samples shares combination
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.